Thu, May 5, 7:30 AM, Zacks
The Zacks Analyst Blog Highlights: Amgen, Gilead, Celgene, Medivation and Biogen
The Zacks Analyst Blog Highlights Amgen, Gilead, Celgene, Medivation and Biogen
Wed, May 4, 11:11 AM, Zacks
Biotech Stock Roundup: Amgen Impresses, Gilead Disappoints in Q1, Biogen to Spin Off Hemophilia
Big names in the biotech sector like Amgen (AMGN) and Gilead (GILD) reported earnings with some hitting the bull's eye and others falling short.